FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

By J. Benedet, H. Bender, Jones Rd, H. Ngan, S. Pecorelli. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2000

1,199 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/e4e8a5d51082f94f40653675f014650a0d9c21cd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. R. Pötter
2. A. Sturdza
3. C. Kirisits
4. K. Tanderup
5. C. Haie-meder
6. L. Tan
7. L. Fokdal
8. P. Georg

Citations in the corpus

• Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. (2016, methodology): “All patients were clinically staged according to the International Federation of Gynaecology and Obstetrics (FIGO) criteria [22].”
• Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials (2009, methodology): “The inclusion criteria were similar in all 3 trials and 18 þ -year-old patients after given written consent were enrolled if they had previously untreated epithelial ovarian cancer FIGO stage IIB-IV.(12) Patients were randomly assigned to 1 of 2 treatment arms consisting of either carboplatin or cis”